Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal

被引:126
|
作者
Shah, Nilesh [2 ]
Pang, Brendan [1 ]
Yeoh, Khay-Guan [2 ,3 ]
Thorn, Shannon [4 ]
Chen, Chien Shiny [2 ,3 ]
Lilly, Michael B. [5 ]
Salto-Tellez, Manuel [1 ,2 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Pathol, Singapore 117595, Singapore
[2] Natl Univ Singapore, Oncol Res Inst, Singapore 117595, Singapore
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Med, Singapore 117595, Singapore
[4] Univ Arizona, Arizona Hlth Sci Ctr, Dept Med, Infect Dis Sect, Tucson, AZ USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
关键词
PIM1; Kinase; Lymphomas; Carcinomas; Target inhibitors;
D O I
10.1016/j.ejca.2008.06.044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vitro experiments have shown the PIM1 kinase to have diverse biological roles in cell survival, proliferation and differentiation. In humans, PIM1 is often expressed in both normal and transformed cells. The PIM1 kinase is a true oncogene implicated in early transformation and tumour progression in haematopoietic malignancies and prostate carcinomas. it is associated with aggressive subgroups of lymphoma, is a marker of poor prognosis in prostate carcinomas and has been suggested to have a role in hormone insensitivity of prostate malignancies. PIM1 has a possible role in other carcinomas with 6p21 genomic alterations. On one hand, PIM1 (due to its role in malignancy) appears to be a promising target for drug development programmes but, on the other hand, the complexity of its molecular structure has posed challenges in the development of PIM1 inhibitors. In this review we discuss PIM1 expression in human tissues (including some new data from our laboratory), its role in human malignancies, as well as the possibilities and challenges in the development of target therapy for PIM1. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2144 / 2151
页数:8
相关论文
共 50 条
  • [31] Pim1 Kinase Functional Effect Depends Upon Intracellular Localization
    Samse, Kaitlen
    Hariharan, Nirmala
    Quijada, Pearl
    Voelkers, Mirko
    Ormachea, Lucia
    Din, Shabana
    Alvarez, Roberto
    Emathinger, Jacqueline
    Mohsin, Sadia
    Sussman, Mark A.
    CIRCULATION RESEARCH, 2014, 115 (12) : E91 - E91
  • [32] Modulation of senescence of prostate tumor cells by the PIM1 protein kinase
    Zemskova, Marina
    Cen, Bo
    Kraft, Andrew
    CANCER RESEARCH, 2009, 69
  • [33] Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease
    Velazquez, Ramon
    Shaw, Darren M.
    Caccamo, Antonella
    Oddo, Salvatore
    MOLECULAR NEURODEGENERATION, 2016, 11
  • [34] Pim1 kinase regulates c-Kit gene translation
    An N.
    Cen B.
    Cai H.
    Song J.H.
    Kraft A.
    Kang Y.
    Experimental Hematology & Oncology, 5 (1)
  • [35] EXPLORING PIM1 AS A MEASURABLE THERAPEUTIC TARGET IN EARLY RHEUMATOID ARTHRITIS
    Marley, Nicola J.
    Anderson, Amy E.
    Nair, Nisha
    Barton, Ann
    Isaacs, John D.
    Pratt, Arthur G.
    RHEUMATOLOGY, 2018, 57
  • [36] Proviral insertion in murine 1 (PIM1) kinase expression and clinical outcomes in advanced breast cancer (ABC)
    Graff, S.
    Elliott, A.
    Mahtani, R.
    Sammons, S.
    Tan, A.
    Nabhan, C.
    Holder, S. L.
    ANNALS OF ONCOLOGY, 2023, 34 : S388 - S389
  • [37] Pim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
    Ramon Velazquez
    Darren M. Shaw
    Antonella Caccamo
    Salvatore Oddo
    Molecular Neurodegeneration, 11
  • [38] p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase
    Zemskova, Marina
    Lilly, Michael B.
    Lin, Ying-Wei
    Song, Jin H.
    Kraft, Andrew S.
    MOLECULAR CANCER RESEARCH, 2010, 8 (08) : 1126 - 1141
  • [39] PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Sutapa Mahata
    Pranab K. Sahoo
    Ranita Pal
    Sinjini Sarkar
    Tanuma Mistry
    Sushmita Ghosh
    Vilas D. Nasare
    Medical Oncology, 39
  • [40] PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
    Mahata, Sutapa
    Sahoo, Pranab K.
    Pal, Ranita
    Sarkar, Sinjini
    Mistry, Tanuma
    Ghosh, Sushmita
    Nasare, Vilas D.
    MEDICAL ONCOLOGY, 2022, 39 (05)